The ASPIRE trial is a clinical research study designed to evaluate the effectiveness and safety of combining novel therapeutic agents with standard treatments for cancer patients. It primarily focuses on the integration of targeted therapies and immunotherapy with conventional chemotherapy and radiation therapy. The trial aims to determine whether these combinations can improve overall survival rates and reduce the recurrence of cancer.
